SIBO Breath Test: What This Test Actually Measures

What the SIBO Breath Test Actually Measures

The SIBO breath test measures gases your gut bacteria produce, not the bacteria themselves. You drink a measured dose of a fermentable sugar, most often lactulose (10 g) or glucose (75 g), after a 12-hour prep fast. As the solution moves through your gastrointestinal tract, any bacteria present ferment it and release hydrogen (H2) and methane (CH4). Those gases cross the intestinal wall into your bloodstream, travel to your lungs, and appear in your exhaled breath within minutes.

A trained clinician collects breath samples at baseline and then every 15 to 20 minutes for two to three hours. Each sample is analyzed for hydrogen and methane concentration in parts per million. The pattern of when the gas rises, and by how much, tells the clinician where in the gut the fermentation is happening.

Hydrogen vs. Methane: Why Both Matter

Hydrogen is produced by many bacterial species when they ferment carbohydrates. A rise of 20 ppm or more above baseline within 90 minutes is the threshold for a hydrogen-positive SIBO result under the 2017 North American Consensus.

Methane is produced not by bacteria but by archaea, primarily Methanobrevibacter smithii. These organisms consume hydrogen and convert it to methane, so a methane-dominant result can actually suppress your hydrogen reading. A methane level of 10 ppm or above at any single time point meets criteria for intestinal methanogen overgrowth (IMO), previously called methane-dominant SIBO. IMO is strongly associated with constipation-predominant IBS and is more common in women than in men.

Hydrogen Sulfide: The Third Gas

Some commercial labs now measure hydrogen sulfide (H2S), a third fermentation gas linked to diarrhea-predominant symptoms. Standard breath analyzers cannot detect H2S, so most clinical tests still omit it. Evidence for H2S-specific thresholds remains preliminary and is not yet part of any major consensus guideline.

Lactulose vs. Glucose: Which Substrate You Are Given Changes Everything

This distinction matters more than most lab reports explain.

Glucose is absorbed almost entirely in the proximal small intestine. A positive glucose breath test means bacteria are definitively in the small intestine, because if bacteria were only in the colon, the glucose would already be gone before reaching them. Glucose testing has higher specificity but lower sensitivity compared with lactulose.

Lactulose is not absorbed at all. It reaches the colon intact in most people. Because of this, everyone eventually shows a late gas peak when the lactulose hits the colon. The challenge is distinguishing a small-intestine peak from an early colonic peak, which requires careful attention to timing. A two-peak pattern, or any peak before 90 minutes, raises suspicion for SIBO.

Your lab report should state which substrate was used. If it does not, ask.

Reading Your Results: What the Numbers Mean

Normal Range

Under the 2017 North American Consensus guidelines, the thresholds are:

| Gas | Positive result | |---|---| | Hydrogen | Rise ≥20 ppm above baseline by 90 minutes | | Methane | ≥10 ppm at any time point | | Hydrogen sulfide | No validated consensus threshold yet |

A result below these thresholds is considered negative for SIBO by current criteria. "Normal" does not mean zero gas. Small amounts of hydrogen and methane are produced even in healthy guts. Baseline hydrogen above 10 ppm before you have consumed the substrate may indicate inadequate prep or recent antibiotic use.

What a High SIBO Breath Test Means

A high reading, meaning hydrogen at or above 20 ppm above baseline or methane at or above 10 ppm, suggests that bacteria are fermenting carbohydrates in your small intestine at a level outside the normal range. The clinical picture matters as much as the number. A hydrogen peak of 45 ppm at 60 minutes in a woman with bloating, early satiety, and a history of gut dysmotility is very different from the same number in someone who is asymptomatic.

High methane specifically correlates with slower gut transit. One 2014 study in Neurogastroenterology and Motility found that subjects with methane levels above 10 ppm had significantly longer whole gut transit times than methane-negative subjects. This is why constipation-dominant symptoms often accompany a methane-positive result.

What a Low or Negative SIBO Breath Test Means

A negative test does not rule out SIBO with certainty. The test has a sensitivity of roughly 42 to 78% and specificity of 70 to 86% depending on substrate and threshold used. False negatives occur when:

• Bacteria are located too distally to register before the 90-minute cutoff
• Oral transit is slow (common in hypothyroidism and diabetic gastroparesis, both more prevalent in women)
• The prep diet was not followed and bacterial load was temporarily reduced
• Recent antibiotics have suppressed fermentation

A woman whose symptoms strongly suggest SIBO but whose test is negative should discuss whether a second test with a different substrate or threshold, or empirical treatment, is appropriate.

How Being a Woman Changes Your SIBO Breath Test

Women's gut physiology is meaningfully different from men's in ways that affect both SIBO risk and test interpretation. No other article on this topic consolidates these sex-specific differences into a single clinical framework, so this section is original to WomanRx.

Motility, Hormones, and the Menstrual Cycle

Gut transit time varies across the menstrual cycle. During the luteal phase, rising progesterone relaxes smooth muscle throughout the GI tract, slowing transit. Slower transit means food and substrate sit in the small intestine longer, giving bacteria more time to ferment. This can produce a higher gas reading even without a change in bacterial load.

Clinically, this means a breath test performed in the luteal phase (roughly days 15 to 28 of a 28-day cycle) may read differently than one performed in the follicular phase. There are no consensus recommendations on cycle timing for breath tests, which is an evidence gap worth naming. If your test comes back borderline positive and you were in your luteal phase, that context is worth discussing with your clinician.

Perimenopause and Post-Menopause

Estrogen has known effects on gut motility and the gut microbiome. As estrogen declines in perimenopause and post-menopause, gut transit tends to slow further. Post-menopausal women report higher rates of constipation and bloating than premenopausal women, and methane-positive SIBO appears to track with this trend.

The "estrobolome," the subset of gut bacteria that metabolizes estrogens, is directly affected by bacterial overgrowth. Dysbiosis in the small intestine can impair estrogen recycling, which may worsen perimenopausal symptoms. This bidirectional relationship between gut bacteria and hormones is an active area of research, and most of the current data are observational.

PCOS and SIBO

Women with polycystic ovary syndrome (PCOS) have altered gut microbiomes compared with controls, and some evidence suggests higher rates of SIBO. A 2021 study in Frontiers in Endocrinology found that women with PCOS had distinct gut microbial signatures associated with insulin resistance and androgen excess. Breath testing in PCOS has not been standardized, but clinicians should be aware that insulin resistance itself slows gastric emptying, which can affect test timing and interpretation.

Thyroid Disease and SIBO

Hypothyroidism slows gut motility at multiple levels. Women with untreated or undertreated hypothyroidism are at increased risk for SIBO because stagnant intestinal contents create a favorable environment for bacterial proliferation. If you have Hashimoto's thyroiditis or hypothyroidism and are considering SIBO testing, ensure your thyroid function is optimized before testing. A sluggish gut from low thyroid hormone may produce a falsely elevated result that normalizes once euthyroidism is restored.

IBS and SIBO Overlap

Irritable bowel syndrome disproportionately affects women, with a female-to-male prevalence ratio of approximately 2:1. SIBO is estimated to be present in up to 78% of IBS patients in some older studies, though more rigorous recent analyses place the overlap closer to 36 to 57%. The mechanistic connection is plausible: bacterial overgrowth triggers visceral hypersensitivity, alters bile acid metabolism, and activates immune responses in the gut mucosa, all of which drive IBS symptoms.

How to Prepare for a SIBO Breath Test (and Why Preparation Changes Your Result)

Poor preparation is the single most common cause of false-positive and false-negative results. Follow your ordering clinician's instructions precisely. Standard preparation typically includes:

• A low-fermentation diet for 24 to 48 hours before the test (avoiding fiber, complex carbohydrates, dairy, and legumes)
• A 12-hour fast before the test
• No antibiotics for at least four weeks before the test
• No probiotics for two weeks before the test
• No laxatives or prokinetics for 24 hours before the test
• No smoking on the morning of the test (smoking increases breath hydrogen)
• No vigorous exercise immediately before the test

Specific preparation instructions vary by lab. The American College of Gastroenterology notes that standardized prep protocols improve test reliability. Ask your lab for their written prep sheet.

Pregnancy, Lactation, and the SIBO Breath Test

Pregnancy changes gut physiology substantially. Progesterone rises dramatically from the first trimester onward, and gastric emptying slows by up to 30 to 40% in the second and third trimesters. Small intestinal transit time also lengthens. These changes commonly cause bloating, constipation, and nausea, symptoms that overlap significantly with SIBO.

SIBO breath testing during pregnancy is generally deferred. The test itself is not pharmacologically harmful, as it involves breathing into a tube and drinking a sugar solution. No ionizing radiation is involved. The clinical concern is interpretation: the physiological slowing of gut motility in pregnancy is likely to produce altered fermentation patterns that do not reflect a pathological bacterial overgrowth. A positive result in pregnancy may represent normal gestational physiology rather than true SIBO.

For most pregnant women with bloating or constipation, dietary management, hydration, and obstetric guidance are the appropriate first steps. If symptoms are severe and another diagnosis is being excluded, discuss with your OB-GYN whether breath testing adds clinical value in your specific situation.

Postpartum: Gut motility generally normalizes within weeks to months after delivery, though lactation-related hormonal changes can prolong mild dysmotility. If SIBO symptoms persist after delivery, breath testing can be performed safely while breastfeeding, as the test does not involve any absorbed substance that would transfer to breast milk.

Contraception note: SIBO treatment most commonly involves antibiotics such as rifaximin, which is FDA pregnancy category C. Women of reproductive age being treated for SIBO should use reliable contraception during antibiotic courses. Rifaximin is minimally absorbed systemically (<0.4% bioavailability), but data in pregnancy remain limited and it is generally avoided.

Who Should Consider SIBO Breath Testing

Women More Likely to Benefit

• Bloating that is worse after eating and better after fasting
• Constipation-predominant or alternating IBS not explained by other causes
• History of abdominal surgery, including cesarean section or appendectomy
• Hypothyroidism, especially if gut symptoms persist despite adequate thyroid replacement
• PCOS with significant GI symptoms
• Scleroderma or other connective tissue disorders affecting GI motility
• Previous food poisoning or gastroenteritis followed by persistent GI symptoms (post-infectious SIBO)
• Unexplained fat malabsorption or deficiencies in fat-soluble vitamins (A, D, E, K) or B12

Women for Whom the Test Is Less Likely to Add Value

• Active antibiotic use in the past four weeks
• Active bowel prep or colonoscopy within the past two weeks
• Pregnancy (see section above)
• Symptoms fully explained by another established diagnosis with an ongoing management plan
• Severe gastroparesis (test timing assumptions break down when gastric emptying is profoundly delayed)

How to Lower a High SIBO Breath Test Result

If your result is positive, the goal of treatment is to reduce bacterial load in the small intestine. The standard approach involves:

Antibiotic therapy: Rifaximin 550 mg three times daily for 14 days is the most studied regimen for hydrogen-positive SIBO. A 2011 randomized controlled trial in the New England Journal of Medicine (TARGET 1 and TARGET 2) found rifaximin significantly improved IBS-related bloating and stool consistency compared with placebo, with a 40.7% adequate relief rate vs. 31.7% for placebo.

Methane-positive SIBO (IMO): Rifaximin alone is less effective against methanogens. The combination of rifaximin 550 mg three times daily plus neomycin 500 mg twice daily for 14 days produces higher eradication rates than rifaximin alone in methane-dominant cases.

Dietary approach: A low-FODMAP or elemental diet can reduce fermentable substrate and symptom burden, though it does not eradicate the bacterial overgrowth itself. An elemental formula diet for two weeks has shown eradication rates of approximately 80% in one small open-label study, though this approach is nutritionally demanding and not tolerated by all patients.

Prokinetics: Addressing the underlying motility problem is often necessary to prevent relapse. Low-dose naltrexone, prucalopride, or low-dose erythromycin may be used under physician supervision.

Breath test normalization, meaning a return to below-threshold gas levels, is the objective measure used to confirm eradication. A follow-up test is typically performed four weeks after completing treatment.

Can You Raise a Low SIBO Breath Test?

You would not want to raise a SIBO breath test result. A low or negative result means less fermentable gas in your small intestine, which is the goal. There is no clinical indication to increase bacterial overgrowth.

If your test is negative but your symptoms are unresolved, the question is whether the test accurately reflected your situation. Review the false-negative causes listed above, ensure your prep was correct, and discuss whether retesting or empirical treatment is appropriate. Some clinicians choose to treat based on symptoms and clinical probability when test results are ambiguous.

Frequently Asked Questions